Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Delayed Quote USD

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

Compare
10.06
+0.03
+(0.30%)
At close: April 3 at 4:00:02 PM EDT
Loading Chart for DMAA
  • Previous Close 10.03
  • Open 10.02
  • Bid 10.01 x 100
  • Ask --
  • Day's Range 10.02 - 10.05
  • 52 Week Range 9.95 - 10.27
  • Volume 2,352
  • Avg. Volume 264,335
  • Market Cap (intraday) 337.182M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: DMAA

View More

Performance Overview: DMAA

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DMAA
0.80%
S&P 500 (^GSPC)
8.25%

1-Year Return

DMAA
0.80%
S&P 500 (^GSPC)
3.55%

3-Year Return

DMAA
0.80%
S&P 500 (^GSPC)
18.71%

5-Year Return

DMAA
0.80%
S&P 500 (^GSPC)
116.85%

Compare To: DMAA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DMAA

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    337.18M

  • Enterprise Value

    337.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: DMAA

View More

Company Insights: DMAA

Research Reports: DMAA

View More